Randomized trial of high dose conformal radiotherapy for prostate cancer: Initial report of acute toxicity.

被引：0
|
作者：
Wilson, J [1 ]
Khoo, V [1 ]
Meyer, L [1 ]
Bidmead, M [1 ]
Warrington, J [1 ]
Helyer, S [1 ]
Gadd, J [1 ]
Huddart, R [1 ]
Horwich, A [1 ]
Dearnaley, D [1 ]
机构：
[1] Royal Marsden NHS Trust, London, England
来源：
BRITISH JOURNAL OF CANCER | 1998年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
021
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [31] Dose-volume analysis of genitourinary toxicity in 3-D conformal radiotherapy for prostate cancer
    Bagala, P.
    Ingrosso, G.
    Falco, M. D.
    Petrichella, S.
    D'andrea, M.
    Rago, M.
    Lancia, A.
    Bruni, C.
    Ponti, E.
    Santoni, R.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S801 - S801
  • [32] High-Dose-RATE Brachytherapy As Monotherapy for Low and Intermediate Risk Prostate Cancer: ACUTE Toxicity of a Randomized Phase II Trial
    Jolicoeur, M.
    Derashodian, T.
    Nguyen-Huynh, T. V.
    Hellmann, E. de Castro
    Mondat, M.
    Nachabe, M.
    Antebi, E.
    Wakil, G.
    Heliou, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E284 - E284
  • [33] HYPOFRACTIONATION VERSUS STANDARD FRACTION IN PROSTATE CANCER: ANALYSIS OF THE ACUTE TOXICITY.
    Saracino, B. M.
    Petrongari, M. G.
    Gomellini, S.
    Arcangeli, S.
    Landoni, V.
    Marzi, S.
    Strigari, L.
    Sperduti, I.
    Arcangeli, G.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S328 - S328
  • [34] Hypofractionated Radiotherapy with or without IGRT in Prostate Cancer: Preliminary Report of Acute Toxicity
    Valeriani, Maurizio
    Monaco, Flavia
    Osti, Mattia Falchetto
    De Sanctis, Vitaliana
    Minniti, Giuseppe
    Enrici, Riccardo Maurizi
    ANTICANCER RESEARCH, 2011, 31 (10) : 3555 - 3558
  • [35] TREATMENT WITH HIGH DOSE RATE PLESIOTHERAPY IN SKIN CANCER. DESCRIPTION OF THE TECHNIQUE AND ACUTE TOXICITY.
    Membrive Conejo, I.
    Reig Castillejo, A. M.
    Foro Arnalot, P.
    Sanz Latiesas, J.
    Rodriguez de Dios, N.
    Lozano Galan, J.
    Lacruz Bassols, M.
    Fernandez-Velilla Cepria, E.
    Quera Jordana, J.
    Jimenez Lahuerta, R.
    Caballero del Pozo, S.
    Lopez Calleja, C.
    Algara Lopez, M. I.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S226 - S226
  • [36] Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial
    Viani, Gustavo Arruda
    Viana, Bruno Silveira
    Chicareli Martin, Jose Eduardo
    Rossi, Bruno Tiago
    Zuliani, Gisele
    Stefano, Eduardo Jose
    CANCER, 2016, 122 (13) : 2004 - 2011
  • [37] Age does not influence acute toxicity during radiotherapy dose escalation for prostate cancer
    Dhadda, A.
    Lakshmanan, D.
    Sokal, M.
    Sundar, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 369 - 369
  • [38] Age does not influence acute toxicity during radiotherapy dose escalation for prostate cancer
    Dhadda, A.
    Lakshmanan, D.
    Sokal, M.
    Sundar, S.
    CLINICAL ONCOLOGY, 2006, 18 (06) : 506 - 507
  • [39] High-dose intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on dosimetry aspects and acute toxicity in the Indian scenario
    De, Sandeep
    Kannan, Venkatesan
    Deshpande, Sudesh
    Anand, Vivek
    Ghadi, Yogesh
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2010, 6 (01) : 58 - 64
  • [40] Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial
    Storey, MR
    Pollack, A
    Zagars, G
    Smith, L
    Antolak, J
    Rosen, I
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03): : 635 - 642
12345